461 filings
NT 20-F
IPCIF
Intellipharmaceutics International Inc.
2 Apr 24
Notice of late annual filing (foreign)
9:03pm
6-K
IPCIF
Intellipharmaceutics International Inc.
13 Mar 24
Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
8:06pm
6-K
IPCIF
Intellipharmaceutics International Inc.
7 Mar 24
Intellipharmaceutics Announces Cease Trade Order
3:21pm
6-K
IPCIF
Intellipharmaceutics International Inc.
26 Feb 24
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
9:11pm
SC 13G/A
IPCIF
Intellipharmaceutics International Inc.
14 Feb 24
Intellipharmaceutics International / ARMISTICE CAPITAL ownership change
2:48pm
UPLOAD
iz49 0esczb8
14 Feb 24
Letter from SEC
12:00am
6-K
hnio16e49u 81rz
9 Feb 24
Intellipharmaceutics International Inc. Announces Stock Option Grant
12:00am
20-F/A
qpa 5vp24o9
6 Feb 24
Annual report (foreign) (amended)
12:00am
6-K
j51nc1e dw34xd
11 Jan 24
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
6:14pm
6-K
4ahqs9 0x
16 Oct 23
Current report (foreign)
5:23pm
6-K
ljvli9wlv5ppq
6 Oct 23
Annual Meeting of Shareholders
11:33am
6-K
3yjb qp479qp
6 Oct 23
Intellipharmaceutics Reports Director Election Results
11:33am
6-K
tpn4gz3ylowg68v
26 Sep 23
Current report (foreign)
5:29pm
6-K
2r0089jl
26 Sep 23
Current report (foreign)
5:23pm
SC 13G/A
ajilcwe6uw 4i8c
14 Feb 23
Intellipharmaceutics International / ARMISTICE CAPITAL ownership change
1:01pm
6-K
vrxrh4ap ic05toom
14 Oct 22
Current report (foreign)
4:22pm
6-K
gpbberfx2amwobixpi
21 Jul 22
Current report (foreign)
5:28pm
6-K
w2ppc1ab10b9n1
15 Jul 22
Primary Document
8:05am
6-K
shd1vpit vkq
27 May 22
Intellipharmaceutics Reports Director Election Results
4:49pm